Real-World Reviews Reveal Why Patients Quit a Newer Insomnia Drug — and It Isn't What the Clinical Trials Showed
A mixed-methods study of 260 online drug reviews, published in Sleep Medicine, found that patients who discontinued lemborexant reported sleep paralysis at nearly three times the rate of those who stayed on it — far above rates seen in clinical trials.